Cargando…

OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis

BACKGROUND: In prisons in England, integrated treatment for opioid use disorder (OUD) is accessible and effective, commonly based on daily supervised consumption of methadone. Treatment limitations (inadequate dosing, nonengagement with care, stigma, diversion and bullying) are noted. Flexible dose,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, Nat, Hard, Jake, Fearns, Colin, Gilman, Mark, Littlewood, Richard, Clegg, Rachael, Parimelalagan, Luxman, Alam, Farrukh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490057/ https://www.ncbi.nlm.nih.gov/pubmed/32982339 http://dx.doi.org/10.2147/CEOR.S256714

Ejemplares similares

Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine
por: Parsons, Graham, et al.
Publicado: (2020)

Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
por: Nguyen, Andrea, et al.
Publicado: (2023)

A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)
por: Khatri, Utsha G., et al.
Publicado: (2022)

Optimising opioid substitution therapy in the prison environment
por: Alam, Farrukh, et al.
Publicado: (2019)

Increased Treatment Engagement and Adherence: Flexible Management with Prolonged-Release Buprenorphine in Treatment of Opioid Dependence
por: Hard, Bernadette
Publicado: (2021)

J. J. P. Oud
por: Wiekart, K.
Publicado: (1965)

Prolonged-Release Buprenorphine Therapy in Opioid Use Disorder Can Address Stigma and Improve Patient Quality of Life
por: Somaini, Lorenzo, et al.
Publicado: (2021)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
por: Phillips-Jackson, Helen, et al.
Publicado: (2020)

The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification
por: Sheard, Laura, et al.
Publicado: (2009)

Afscheid van het oude normaal
por: Otto, Wim
Publicado: (2021)

Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study
por: Hard, Bernadette, et al.
Publicado: (2023)

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
por: Scott, Travis M., et al.
Publicado: (2021)

The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification
por: Sheard, Laura, et al.
Publicado: (2009)

The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project pilot study: protocol for a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification
por: Sheard, Laura, et al.
Publicado: (2007)

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report
por: Guillou-Landreat, Morgane, et al.
Publicado: (2021)

Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians
por: Huskamp, Haiden A., et al.
Publicado: (2023)

Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
por: Springer, Sandra Ann, et al.
Publicado: (2010)

Successful Treatment of Opioid Dependence with Flexible Doses of Injectable Prolonged Release Buprenorphine
por: D'Agnone, Oscar
Publicado: (2019)

Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study
por: Ling, Walter, et al.
Publicado: (2020)

Successful outcomes using Long Acting Buprenorphine (LAB - Buvidal) to treat Codeine, Tramadol and other Opioid Analgesia Dependencies (OAD) in Wales during the Pandemic
por: Melichar, J., et al.
Publicado: (2022)

Internet veertig jaar, www twintig jaar oud
Publicado: (2009)

Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice
por: Kakko, Johan, et al.
Publicado: (2018)

Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
por: Springer, Sandra A., et al.
Publicado: (2012)

Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021
por: Thakrar, Ashish P., et al.
Publicado: (2021)

Detection of methadone and buprenorphine in urine samples from inmates of German prisons
por: Franchetti, Giorgia, et al.
Publicado: (2023)

Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUD
por: Staton, Michele, et al.
Publicado: (2021)

Systematic Review of the Safety and Tolerability of Injectable Prolonged-Release Buprenorphine (Buvidal) in Adults With Opioid Dependence
por: Williams, Laura, et al.
Publicado: (2023)

Internet 40 jaar en www 20 jaar oud
Publicado: (2009)

Acute effects of inhaling Oud incense on voice of Saudi adults
por: Mesallam, Tamer A., et al.
Publicado: (2015)

Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
por: Berger, Olivia, et al.
Publicado: (2021)

COVID pandemic effect on prenatal care utilization in women with OUD
por: Stewart, Lauren, et al.
Publicado: (2023)

A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons
por: Bagnall, Anne-Marie, et al.
Publicado: (2015)

Effects of the COVID-19 pandemic on the mental health of prisoners
por: Hewson, Thomas, et al.
Publicado: (2020)

Implementing buprenorphine prolonged-release injection using a health at the margins approach for transactional sex-workers
por: Gittins, Rosalind, et al.
Publicado: (2023)

Telehealth sustains patient engagement in OUD treatment during COVID-19
por: Langabeer, James R., et al.
Publicado: (2021)

184 Exploring facility level differences in medication-based treatment of OUD
por: Thornton, Vera, et al.
Publicado: (2023)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

COVID-19: digital equivalence of health care in English prisons
por: Edge, Chantal, et al.
Publicado: (2020)

Extended-release monthly buprenorphine injection
por: Cuperfain, Ari B., et al.
Publicado: (2023)

The effects of COVID-19 on self-harm in UK prisons
por: Hewson, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_abolb40ksgcg5ghnqjt96vs5g8